BioCentury
ARTICLE | Company News

AstraZeneca, Pinnacle sales and marketing update

February 25, 2008 8:00 AM UTC

AstraZeneca's MedImmune Inc. subsidiary granted Pinnacle exclusive rights to market and distribute Ethyol amifostine in western Europe, Turkey and Israel. The chemoprotectant thiol drug is approved t...